Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Parkinson DiseaseREM Sleep Behavior DisorderDementia, Lewy Body
Interventions
DEVICE

PET/CT with 18-FDG

FDG-PET scans will be acquired in a Siemens Biograph Vision Quadra PET/CT (Siemens, Germany) at 30-minute post-injection of approximately 80 MBq 18F-FDG. The duration of the acquisition is 20 minutes. The PET images will be reconstructed with the vendor's time of flight (TOF) point-spread-function (PSF) algorithm, following corrections for randoms, scatter, and decay. Attenuation correction will be performed first using low-dose CT.

DEVICE

SPECT : 123 I-FP-CIT (DATSCAN)

DaT-Scans will be acquired in a GE Discovery NM/CT 670 Pro™. After injection of approximately 110 MBq 123I-FP-CIT, images will be acquired within 4 h post-injection. The duration of the acquisition is 35 minutes.

DEVICE

MRI

MRI examination to exclude structural brain anomalies.

Trial Locations (1)

3010

RECRUITING

Inselspital, University Clinic for Nuclear Medicine, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER